Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 852Neoplasms 643Prostatic Neoplasms 439Lung Neoplasms 359Colorectal Neoplasms 327Carcinoma, Non-Small-Cell Lung 318Leukemia, Myeloid, Acute 251Pancreatic Neoplasms 218Brain Neoplasms 202Multiple Myeloma 198Neoplasm Metastasis 191Carcinoma, Hepatocellular 178Head and Neck Neoplasms 176Glioblastoma 167Precursor Cell Lymphoblastic Leukemia-Lymphoma 166Melanoma 153Ovarian Neoplasms 149Squamous Cell Carcinoma of Head and Neck 148Rectal Neoplasms 134Recurrence 132Hematologic Neoplasms 125Sarcoma 124Uterine Cervical Neoplasms 117Stomach Neoplasms 116Carcinoma, Renal Cell 115Triple Negative Breast Neoplasms 114Glioma 114Motor Activity 100Myelodysplastic Syndromes 96Esophageal Neoplasms 96

Interventions

trastuzumab deruxtecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Breast Cancer Metastatic × 90 days × Clear all
NCT07586215 2026-05-14

PREDICT-HER

Fudan University

Recruiting
100 enrolled
Breast

Breast Cancer Metastatic

NCT06750484 2026-05-06

Trial of Trastuzumab Deruxtecan in Previously Treated HER2

Yale University

Phase 2 Recruiting
40 enrolled
Breast

Breast Cancer Metastatic

NCT06706570 2026-03-24

PIK3CA Mutational Status Assessment

European Institute of Oncology

Recruiting
100 enrolled
Breast

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡